These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9068920)

  • 61. Thrombolytic therapy for myocardial infarction.
    Andreotti F
    N Engl J Med; 1998 Feb; 338(8):546; author reply 547. PubMed ID: 9471558
    [No Abstract]   [Full Text] [Related]  

  • 62. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment.
    Carlson SE; Aldrich MS; Greenberg HS; Topol EJ
    Arch Neurol; 1988 Oct; 45(10):1070-3. PubMed ID: 3140769
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X; George MG; Yang Q; Gillespie C
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
    Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
    Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction.
    Lagares A; Gómez PA; Lobato RD; Alén JF; Campollo J; Benito-León J
    Surg Neurol; 1999 Dec; 52(6):623-6. PubMed ID: 10660031
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative macular degeneration.
    Djalilian AR; Cantrill HC; Samuelson TW
    Eur J Ophthalmol; 2003; 13(1):96-8. PubMed ID: 12635684
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
    Barsam A; Heatley CJ; Herbert L
    Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thrombolytic therapy for coronary occlusion.
    Thompson PL
    Med J Aust; 1992 Jul; 157(2):75-7. PubMed ID: 1630392
    [No Abstract]   [Full Text] [Related]  

  • 70. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 71. Thrombolytic-related complication in a case of misdiagnosed myocardial infarction.
    Irivbogbe O; Mirrer B; Loarte P; Gale M; Cohen R
    Acute Card Care; 2014 Jun; 16(2):83-7. PubMed ID: 24749992
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 73. Conservative management complications after thrombolytic therapy.
    Mohler ER; Stark KS; Kent KM
    Am Heart J; 1991 Feb; 121(2 Pt 1):591-3. PubMed ID: 1899317
    [No Abstract]   [Full Text] [Related]  

  • 74. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diffuse Alveolar Hemorrhage as a Complication of Intrapleural Fibrinolytic Therapy.
    Shah RM; Krochmal R; Pickering EM; Burrows W; Sachdeva A
    J Bronchology Interv Pulmonol; 2017 Oct; 24(4):e54-e56. PubMed ID: 28957896
    [No Abstract]   [Full Text] [Related]  

  • 76. [Lingual haematoma after thrombolysis for acute myocardial infarction].
    Jaffrelot M; Bourrigan P; Cracan A; Dewilde J; Mehu G
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):306-7. PubMed ID: 15792570
    [No Abstract]   [Full Text] [Related]  

  • 77. Intraventricular bleeding after the use of thrombolytics in a cocaine user.
    LoVecchio F; Nelson L
    Am J Emerg Med; 1996 Nov; 14(7):663-4. PubMed ID: 8906766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Fever after an acute myocardial infarct].
    Castro A; Antorrena I; González C
    Rev Esp Cardiol; 1999 Dec; 52(12):1146-7. PubMed ID: 10659660
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiac tamponade early after thrombolysis for acute myocardial infarction: a rare but not reported hemorrhagic complication.
    Renkin J; de Bruyne B; Benit E; Joris JM; Carlier M; Col J
    J Am Coll Cardiol; 1991 Jan; 17(1):280-5. PubMed ID: 1898952
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultrathrombolysis.
    Topol EJ
    J Am Coll Cardiol; 1990 Apr; 15(5):922-4. PubMed ID: 2107238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.